Gordon Brothers Acquires Telefunken
Boston, Aug. 14, 2023 (GLOBE NEWSWIRE) — Gordon Brothers, the global advisory and investment firm, has acquired the global consumer electronics brand Telefunken. Based in Frankfurt, Germany, Telefunken has become
Boston, Aug. 14, 2023 (GLOBE NEWSWIRE) — Gordon Brothers, the global advisory and investment firm, has acquired the global consumer electronics brand Telefunken. Based in Frankfurt, Germany, Telefunken has become
BELLINGHAM, Washington, 11 août 2023 (GLOBE NEWSWIRE) — eXp Realty®, le cabinet de courtage le plus axé sur les agents de la planète (« the most agent-centric real estate brokerage
BELLINGHAM, Wash., Aug. 11, 2023 (GLOBE NEWSWIRE) — A eXp Realty®, “the most agent-centric real estate brokerage on the planet™” e a principal subsidiária da eXp World Holdings, Inc. (Nasdaq:
eXp Realty Exceeds 1,000-Agent Milestone in South Africa BELLINGHAM, Wash., Aug. 10, 2023 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core
The company’s Indian subsidiary signs its first full-suite customer partnership in the region with HDFC ERGO Mumbai, Aug. 09, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies India LLP, a subsidiary
ABU DHABI, Émirats arabes unis, 04 août 2023 (GLOBE NEWSWIRE) — L’Université d’intelligence artificielle Mohamed bin Zayed (MBZUAI) a ouvert deux nouveaux départements et lancé quatre programmes d’études supérieures dans
ABU DHABI, Emirados Árabes Unidos, Aug. 04, 2023 (GLOBE NEWSWIRE) — A Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) estabeleceu dois novos departamentos e quatro programas de pós-graduação associados
جامعة محمد بن زايد للذكاء الاصطناعي تطلق برامج في علم الروبوتات وعلوم الحاسوب تلبية للطلب المتزايد على هذه التخصصات على مستوى العالم أبوظبي، الإمارات العربية المتحدة، 3 أغسطس 2023: أطلقت
ABU DHABI, United Arab Emirates, Aug. 03, 2023 (GLOBE NEWSWIRE) — Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has established two new departments and four associated graduate programs dedicated
L’étude a montré que l’obéxélimab produisait une amélioration clinique rapide, forte et soutenue, y compris une rémission clinique complète, chez la plupart des patients atteints de ML-IgG4 active Les résultats